KindredBio     Print Page | Close Window

Investor Overview

KindredBio is focused on bringing breakthrough human products and innovative new technologies to veterinary medicine to address unmet clinical needs and provide benefits to animal co... 

Stock Information

NASDAQ CM$15.15
Change (%)0.00 (0.00%)
Volume0
Data as of 08/14/18 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.

NEWS

Kindred Biosciences Announces Second Quarter 2018 Financial Results

August 9, 2018

SAN FRANCISCO, Aug. 9, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Announce Second Quarter 2018 Financial Results

July 16, 2018

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences Announces Commercial Availability of Mirataz® (mirtazapine transdermal ointment) to Veterinarians in the United States

July 9, 2018

SAN FRANCISCO, July 9, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...